Enter your login e-mail to the account
Search
- New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - The genetic profile is determinating the choice of treatment of de-novo patients with chronic lymphocytic leukemia
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD., MUDr. Jozef Lukáš, PhD.
(2/2024, Review articles ) - Chronic lymphocytic leukemia - how to treat a patient with relapsed or refractory disease in the era of signaling pathway inhibitors
MUDr. Firas Farkaš, PhD.
(1/2022, Case reports ) - Waldenström‘s macroglobulinemia and treatment
MUDr. Radoslav Greksák, PhD.
(1/2019, Review articles ) - Kritériá minimálnej reziduálnej choroby pri chronickej lymfocytovej leukémii
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(2/2018, Review articles ) - New EBMT’s recommendations for GvHD prophylaxis and treatment
MUDr. Firas Farkaš, PhD.
(2/2025, Review articles ) - Relapsed/refractory diffuse large B-cell lymphoma
MUDr. Miriam Ladická
(4/2015, Spectrum ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - Indolentné B-bunkové non-Hodgkinove lymfómy – úvodné slovo
Prof. MUDr. Elena Tóthová, CSc.
(1/2017, Spectrum ) - Diffuse large B-cell lymphoma
MUDr. Andrej Vranovský, PhD., MUDr. Michaela Sojáková
(2/2014, Main topic ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - A new era in the treatment of chronic lymphocytic leukemia: venetoclax as a tool for modern therapy – a retrospective group from Slovakia
MUDr. Firas Farkaš, PhD., Prof. MUDr. Mikuláš Hrubiško, CSc., MUDr. Zdenka Štefániková, MUDr. Zuzana Sninská, PhD., MUDr. Eva Luptáková, MUDr. Jana Juranová, MUDr. Ladislav Fekete, MUDr. Enikő Radi, MUDr. Eva Dingová, prof. MUDr. Angelika Bátorová, PhD.
(3/2025, Original articles ) - Správa z ASH
MUDr. Andrej Vranovský, PhD.
(2/2014, Events ) - Treatment of relapse and refractory chronic lymphocytic leukemia
MUDr. Natália Štecová
(5/2014, Oncohematology Review ) - Ibrutinib in treatment of Waldenström´s makroglobulinemia – case report
MUDr. Aneta Matysová
(4/2017, Original articles & case reports ) - Suplement - Stratégia liečby malígnych lymfómov
(1/2018, online attachment ) - Prognostické faktory pri chronickej lymfocytovej leukémii
MUDr. Ľudmila Demitrovičová, PhD.
(4/2018, Review articles )
- Nové liečivá v EÚ registrované v roku 2014 (IV.)
PharmDr. Peter Stanko, Mgr. Zuzana Černáková
(3-4/2015, New drugs )